This phenomenon corresponds to relatively low ASGR and TACC3 baseline expression patterns in quiescent liver tissue.47 In an orthotopic HCC model, regular monitoring revealed sustained therapeutic efficacy characterized by rapid and durable TACC3 mRNA suppression without transcriptional rebound (Supplementary Fig. 9g, h). Here, TACC3 is linked to hepatocellular carcinoma.